Showing results (1721-1730 of 1,911) with videos related to

Sort By:
Pageof 192
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2012
Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma modelMichelle J Lee, Beryl A Hatton, Elisabeth H Villavicencio, et al.
The ISME Journal|March 29, 2024
Environment-specific virocell metabolic reprogrammingCristina Howard-Varona, Morgan M Lindback, Jane D Fudyma, et al.
Obesity (Silver Spring, Md.)|May 29, 2019
Deconstructing Weight Management Interventions for Young Adults: Looking Inside the Black Box of the EARLY Consortium TrialsDeborah F Tate, Leslie Lytle, Kristen Polzien, et al.
JAMA Pediatrics|June 7, 2021
Evaluation of Emergency Department Pediatric Readiness and Outcomes Among US Trauma CentersCraig D Newgard, Amber Lin, Lenora M Olson, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|May 9, 2022
Challenges and Opportunities in Stroke Nursing Research: Global Views From a Panel of Nurse ResearchersSheena Ramazanu, Cynthia Bautista, Theresa Green, et al.
Journal of the American Society of Nephrology : JASN|August 23, 2017
Targeting Anti-TGF-<i>β</i> Therapy to Fibrotic Kidneys with a Dual Specificity Antibody ApproachSteve McGaraughty, Rachel A Davis-Taber, Chang Z Zhu, et al.
Cancer Cell|April 2, 2014
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastomaMarie Morfouace, Anang Shelat, Megan Jacus, et al.
Human Molecular Genetics|May 18, 2000
Decreased expression of striatal signaling genes in a mouse model of Huntington's diseaseR Luthi-Carter, A Strand, N L Peters, et al.
Journal of Medicinal Chemistry|January 16, 2009
Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancerThomas D Penning, Gui-Dong Zhu, Viraj B Gandhi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Pageof 192